fluoxetine has been researched along with prazosin in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (10.87) | 18.7374 |
| 1990's | 9 (19.57) | 18.2507 |
| 2000's | 14 (30.43) | 29.6817 |
| 2010's | 17 (36.96) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ang, KK; Arkin, MR; Chen, S; Doyle, PS; Engel, JC; McKerrow, JH | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Sen, S; Sinha, N | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Maj, J; Rogóz, Z; Skuza, G; Sowińska, H | 1 |
| Bennett, GW; Fone, KC; Heal, DJ; Johnson, JV; Marsden, CA | 1 |
| Gonzales, RA; Moerschbaecher, JM; Mosaddeghi, M | 1 |
| Haynes, J; Pennefather, JN | 1 |
| Woolverton, WL | 1 |
| Snoddy, AM; Tessel, RE | 1 |
| Fawcett, JP; Menkes, DB; Patel, PP | 1 |
| Kleven, MS; Koek, W | 1 |
| Dailey, JW; Jobe, PC; Steenbergen, JL; Yan, QS | 1 |
| Chang, HC; Cheng, JT; Hsieh, CH; Hsieh, JT; Law, HS | 1 |
| Borda, E; Busch, L; Wald, M | 2 |
| Chariot, J; Nagain-Domaine, C; Presset, O; Rozé, C | 1 |
| Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Pallàs, M; Pubill, D; Sureda, FX | 1 |
| Hébert, C; Lalonde, R; Reader, TA; Strazielle, C | 1 |
| Dlaboga, D; Dziedzicka-Wasylewska, M; Maj, J; Rogóz, Z; Skuza, G | 1 |
| Abdali, SA; Kalsner, S | 1 |
| Hodgson, WC; Ramasamy, S; Ventura, S | 1 |
| Herndon, JG; Killiany, RJ; Luebke, JI; Moore, TL; Moss, MB; Rosene, DL; Schettler, SP | 1 |
| Greenup, JL; Leverenz, JB; Peskind, ER; Raskind, MA; Szot, P; White, SS | 1 |
| Dhingra, D; Sharma, A | 1 |
| Arai, Y; Chancellor, MB; de Groat, WC; Kaiho, Y; Kamo, I; Yoshimura, N | 1 |
| Platt, DM; Rowlett, JK; Spealman, RD | 1 |
| Aiso, S; Ito, M; Katada, M; Kawasaki, A; Matsuoka, M; Nishizawa, K; Terashita, K; Torii, K | 1 |
| Brocardo, PS; Budni, J; Kaster, MP; Rodrigues, AL; Santos, AR | 1 |
| Bhide, N; Gudelsky, GA; Pachmerhiwala, R; Straiko, M | 1 |
| Cui, CC; Feng, J; Xu, HL; Yi, LT; Zhan, X; Zhou, LP | 1 |
| Costentin, J; Do Rego, JC; Müller, LG; Nunes, JM; Rates, SM; Stein, AC; Stolz, ED; Viana, AF; von Poser, GL | 1 |
| Boeira, SP; de Gomes, MG; Del Fabbro, L; Filho, CB; Goes, AT; Jesse, CR; Souza, LC | 1 |
| Chhillar, R; Dhingra, D | 1 |
| Asano, K; Egawa, S; Furuta, A; Kimura, S; Suzuki, Y; Yoshimura, N | 1 |
| Buchanan, GF; Dayton, KG; Kruse, SW; Purnell, BS; Rosner, JI | 1 |
| An, H; Chen, S; He, Z; Hu, B; Qi, D; Sun, Y; Wang, M; Wei, Y | 1 |
1 review(s) available for fluoxetine and prazosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
45 other study(ies) available for fluoxetine and prazosin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocytes; High-Throughput Screening Assays; Humans; Image Processing, Computer-Assisted; Muscle, Skeletal; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.
Topics: Animals; Antidepressive Agents; Benzazepines; Citalopram; Dizocilpine Maleate; Fluoxetine; Imipramine; Isomerism; Male; Maprotiline; Motor Activity; Prazosin; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures; Sulpiride | 1992 |
TRH-catecholamine interactions in brain and spinal cord.
Topics: Animals; Catecholamines; Cerebral Ventricles; Clonidine; Fluoxetine; Hypothalamus; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Motor Activity; Norepinephrine; Phenoxybenzamine; Prazosin; Rats; Rats, Inbred Strains; Reference Values; Spinal Cord; Stereotyped Behavior; Thyrotropin-Releasing Hormone | 1989 |
Effect of monoamine uptake inhibitors on norepinephrine-stimulated phosphatidylinositol hydrolysis in rat cortex.
Topics: Animals; Cerebral Cortex; Cocaine; Desipramine; Fluoxetine; In Vitro Techniques; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Phosphatidylinositols; Prazosin; Rats; Receptors, Adrenergic, alpha | 1989 |
Alpha 1-and alpha 2-adrenoceptors of the circular myometrium from the dioestrous guinea-pig.
Topics: Adrenergic beta-Antagonists; Animals; Diestrus; Estrus; Female; Fluoxetine; Guinea Pigs; Myometrium; Norepinephrine; Phenylephrine; Prazosin; Propanolamines; Receptors, Adrenergic, alpha; Uterine Contraction | 1988 |
Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys.
Topics: Animals; Cocaine; Female; Fluoxetine; Macaca mulatta; Male; Norepinephrine; Prazosin; Psychomotor Performance; Reinforcement, Psychology; Self Administration | 1987 |
Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice.
Topics: Amphetamine; Animals; Cocaine; Cues; Discrimination, Psychological; Fluoxetine; Male; Mice; Mice, Inbred ICR; Motor Activity; Pimozide; Prazosin; Propranolol; Stereotyped Behavior | 1985 |
Antidepressant treatment and chemical sympathectomy fail to modulate alpha 1-adrenoceptor sensitivity in mouse eye.
Topics: Administration, Topical; Amitriptyline; Animals; Antidepressive Agents; Benzamides; Desipramine; Down-Regulation; Fluoxetine; Injections, Intraperitoneal; Male; Methoxamine; Mice; Moclobemide; Oxidopamine; Phentolamine; Phenylephrine; Prazosin; Pupil; Receptors, Adrenergic, alpha-1; Sympathectomy, Chemical; Time Factors | 1993 |
Discriminative stimulus properties of cocaine: enhancement by monoamine reuptake blockers.
Topics: Animals; Cocaine; Desipramine; Discrimination Learning; Dopamine; Dose-Response Relationship, Drug; Fluoxetine; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Serotonin; Ventral Tegmental Area | 1998 |
Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Anticonvulsants; Desipramine; Drug Interactions; Epilepsy; Female; Fluoxetine; Idazoxan; Methoxamine; Microinjections; Norepinephrine; Phenylephrine; Prazosin; Rats; Rats, Inbred Strains; Superior Colliculi; Synaptic Transmission | 1998 |
In vivo evaluation of serotonergic agents and alpha-adrenergic blockers on premature ejaculation by inhibiting the seminal vesicle pressure response to electrical nerve stimulation.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Clomipramine; Dose-Response Relationship, Drug; Ejaculation; Electric Stimulation; Fluoxetine; Imipramine; Male; Prazosin; Pressure; Rats; Rats, Wistar; Seminal Vesicles; Serotonin; Serotonin Agents; Sexual Dysfunction, Physiological; Splanchnic Nerves; Sympatholytics | 1998 |
Long-term treatment with fluoxetine associates with peripheral effects on rat vas deferens contractility.
Topics: Adrenergic Agents; Animals; Antidepressive Agents, Second-Generation; Binding Sites; Calcium; Cyclooxygenase Inhibitors; Fluoxetine; Indomethacin; Isoproterenol; Ketanserin; Male; Muscle Contraction; Nitroprusside; Norepinephrine; Prazosin; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Vas Deferens; Verapamil | 1999 |
Modulation of external pancreatic secretion by endogenous norepinephrine: study with a norepinephrine uptake blocker in the rat.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Deoxyglucose; Electric Stimulation; Fluoxetine; Idazoxan; Kinetics; Male; Norepinephrine; Pancreas; Prazosin; Propranolol; Rats; Rats, Wistar; Vagus Nerve; Yohimbine | 1999 |
Assessment of the adrenergic effects of orphenadrine in rat vas deferens.
Topics: Adrenergic Agents; Animals; Atropine; Binding, Competitive; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Epididymis; Fluoxetine; In Vitro Techniques; Ligands; Male; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Norepinephrine; Orphenadrine; Phencyclidine; Prazosin; Rats; Rats, Sprague-Dawley; Vas Deferens | 1999 |
Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Autoradiography; Basal Ganglia; Brain Stem; Cerebral Cortex; Disease Models, Animal; Female; Fluoxetine; Hypothalamus; Idazoxan; Limbic System; Mice; Mice, Neurologic Mutants; Norepinephrine; Prazosin; Propanolamines; Purkinje Cells; Radioligand Assay; Receptors, Adrenergic; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Spinocerebellar Degenerations; Thalamus; Tritium | 1999 |
Influence of castration on the response of the rat vas deferens to fluoxetine.
Topics: Adrenergic alpha-Antagonists; Animals; Calcium; Castration; Cocaine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoxetine; Male; Muscle Contraction; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Prazosin; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Testosterone; Vas Deferens | 2000 |
Effect of repeated treatment with tianeptine and fluoxetine on the central alpha(1)-adrenergic system.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aggression; Animals; Binding, Competitive; Brain Chemistry; Cerebral Cortex; Clonidine; Exploratory Behavior; Fluoxetine; Hyperkinesis; Male; Methoxamine; Phenylephrine; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Selective Serotonin Reuptake Inhibitors; Thiazepines | 2001 |
Rate-independent inhibition by norepinephrine of 5-HT release from the somadendritic region of serotonergic neurons.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Dendrites; Dose-Response Relationship, Drug; Electric Stimulation; Feedback; Fluoxetine; Mesencephalon; Methiothepin; Neural Inhibition; Neurons; Norepinephrine; Phenylephrine; Prazosin; Rabbits; Raphe Nuclei; Receptors, Adrenergic; Serotonin; Serotonin Antagonists; Yohimbine | 2001 |
Protein kinase C and the sub-sensitivity and sub-reactivity of the diabetic rat prostate gland to noradrenaline.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atropine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Fluoxetine; Immunohistochemistry; Indoles; Male; Maleimides; Methoxamine; Muscarinic Antagonists; Naphthalenes; Norepinephrine; Prazosin; Propranolol; Prostate; Protein Kinase C; Rats; Rats, Wistar | 2002 |
Cognitive impairment in aged rhesus monkeys associated with monoamine receptors in the prefrontal cortex.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Age Factors; Aging; Analysis of Variance; Animals; Autoradiography; Behavior, Animal; Benzazepines; Brain Mapping; Clonidine; Cocaine; Cognition Disorders; Discrimination Learning; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Fluoxetine; Macaca mulatta; Male; Membrane Proteins; Memory; Nerve Tissue Proteins; Neuropsychological Tests; Prazosin; Prefrontal Cortex; Radioligand Assay; Receptors, Catecholamine; Statistics as Topic; Tritium | 2005 |
Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Dendrites; Female; Fluoxetine; Hippocampus; Humans; Idazoxan; In Situ Hybridization; Lewy Body Disease; Locus Coeruleus; Male; Middle Aged; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Prazosin; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; RNA, Messenger; Tetralones; Tyrosine 3-Monooxygenase | 2006 |
Antidepressant-like activity of n-hexane extract of nutmeg (Myristica fragrans) seeds in mice.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Dopamine Antagonists; Drug Interactions; Fenclonine; Fluoxetine; Hexanes; Imipramine; Male; Mice; Motor Activity; Myristica; Plant Extracts; Prazosin; Seeds; Serotonin Antagonists; Sulpiride; Swimming | 2006 |
Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Female; Fluoxetine; Norepinephrine; Phentolamine; Prazosin; Pressure; Rats; Rats, Sprague-Dawley; Sneezing; Urethra; Urinary Incontinence, Stress; Vagina | 2007 |
Noradrenergic mechanisms in cocaine-induced reinstatement of drug seeking in squirrel monkeys.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Animals; Behavior, Addictive; Behavior, Animal; Clonidine; Cocaine; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Drug Interactions; Extinction, Psychological; Fluoxetine; Flupenthixol; Grooming; Hydrocortisone; Injections, Intravenous; Norepinephrine; Piperazines; Prazosin; Propranolol; Receptors, Adrenergic, alpha-2; Saimiri; Saliva; Self Administration; Thiophenes | 2007 |
Antidepressant-like effect of Cordyceps sinensis in the mouse tail suspension test.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Bupropion; Chromatography, Supercritical Fluid; Clorgyline; Cordyceps; Desipramine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Fluoxetine; Head Movements; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Motor Activity; Prazosin; Serotonin Antagonists; Sulpiride; Water | 2007 |
Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Depression; Female; Fenclonine; Fluoxetine; Folic Acid; Hindlimb Suspension; Injections, Intraventricular; Male; Mice; Motor Activity; Norepinephrine; Prazosin; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Swimming; Yohimbine | 2008 |
Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain.
Topics: Animals; Brain; Fever; Fluoxetine; Glucose; Glycogenolysis; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Serotonin | 2010 |
Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin.
Topics: Adrenergic Antagonists; Animals; Antidepressive Agents; Benzazepines; Cyproheptadine; Depression; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Flavones; Fluoxetine; Hindlimb Suspension; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperazines; Prazosin; Propranolol; Pyridines; Serotonin Antagonists; Sulpiride; Swimming; Yohimbine | 2011 |
Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Benzazepines; Biogenic Monoamines; Bupropion; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fenclonine; Fluoxetine; Hypericum; Imipramine; Immobility Response, Tonic; Locomotion; Male; Mice; Mice, Inbred Strains; Phloroglucinol; Plant Extracts; Prazosin; Rats; Rats, Wistar; Receptors, Catecholamine; Sulpiride; Vesicular Monoamine Transport Proteins; Yohimbine | 2012 |
Evidence for the involvement of the serotonergic 5-HT(1A) receptors in the antidepressant-like effect caused by hesperidin in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Exploratory Behavior; Fluoxetine; Hesperidin; Hindlimb Suspension; Immobility Response, Tonic; Male; Mice; Motor Activity; Prazosin; Receptor, Serotonin, 5-HT1A | 2013 |
Antidepressant-like activity of ellagic acid in unstressed and acute immobilization-induced stressed mice.
Topics: Animals; Antidepressive Agents; Ellagic Acid; Emotions; Fenclonine; Fluoxetine; Guanidines; Hindlimb Suspension; Immobilization; Indazoles; Male; Mice; Motor Activity; Nitrites; Prazosin; Restraint, Physical; Stress, Psychological; Sulpiride; Swimming | 2012 |
Noradrenergic Mechanisms Controlling Urethral Smooth and Striated Muscle Function in Urethral Continence Reflex in Rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic Neurons; Animals; Benzamidines; Bungarotoxins; Female; Fluoxetine; Medetomidine; Muscle, Smooth; Muscle, Striated; Norepinephrine; Prazosin; Rats; Rats, Sprague-Dawley; Reflex; Urethra | 2015 |
Effect of monoamine reuptake inhibition and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Citalopram; Duloxetine Hydrochloride; Electroshock; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Prazosin; Reboxetine; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Sudden Unexpected Death in Epilepsy | 2019 |
Organic Cation Transporters are Involved in Fluoxetine Transport Across the Blood-Brain Barrier
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Blood-Brain Barrier; Chromatography, Liquid; Corticosterone; Endothelial Cells; Fluoxetine; Humans; Neoplasm Proteins; Prazosin; Rats; Tandem Mass Spectrometry | 2022 |